Oncoinvent oncoinvent.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Oncoinvent is developing therapeutics to combat various cancers based on delivery of tumour-cell killing doses of radiation and/or immunotargeting of tumor cells. The firm's preclinical and discovery-stage pipeline spans radiotherapeutic, radioimmunotherapeutic, and immunotherapeutic products, including proprietary and licensed antibodies, for treating a range of solid cancers. Lead candidate Radspherin is a radium-based, alpha-emitting microsphere therapy designed to target metastases in body c...Show all

Oncoinvent is developing therapeutics to combat various cancers based on delivery of tumour-cell killing doses of radiation and/or immunotargeting of tumor cells. The firm's preclinical and discovery-stage pipeline spans radiotherapeutic, radioimmuno...Show all

Company (Alive / Active)

Phone: +47 22 18 33 05

Fax:

Kjelsaasvn. 168 B

Oslo, NO-0884
Norway

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oncoinvent $25M Feb 9, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oncoinvent Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Monoclonal antibody and derivatives Sep 24, 2014 Oct 10, 2017 Patent
Radiotherapeutic particles and suspensions Jul 13, 2015 Jan 10, 2017 Patent